Genotype-Phenotype Associations of APC Mutations With Pouch Adenoma in Patients With Familial Adenomatous Polyposis

Background: Patients with familial adenomatous polyposis (FAP) may carry various adenomatous polyposis coli (APC) mutations. However, genotype-phenotype correlation for APC mutations is still debated and is yet to be evaluated with regard to pouch polyp formation. Objective: To evaluate the association between APC mutation type and exon location and the outcome of pouch adenoma. Design Setting and Patients: Forty-five FAP patients with defined pathogenic APC mutations, who underwent total proctocolectomy and ileal pouch anal anastomosis were classified by mutation type and location. Analysis was conducted for clinical and endoscopic parameters. Results: Twenty patients had either indel/deletion mutations and 25 had nonsense/missense mutations. The indel/deletion group was associated with higher prevalence of preoperative hundreds of colonic adenomas (66.7% vs. 30%; P=0.030), lower rates of stapled versus sewn anastomosis (46.7% vs. 76%; P=0.060), of single stage surgery (13.3% vs. 44%; P=0.045) and with higher pouch adenoma formation rate (50% vs. 8%; P=0.002). Twenty-seven were carriers of exons 1 to 14 mutations and 18 were carriers of exon 15 mutations. Carriers of exon 15 mutations had higher prevalence of preoperative hundreds of colonic adenomas (55.6% vs. 22.2%; P=0.003) and a higher tendency for pouch and cuff adenoma formation rate. Adjusted odds ratio for pouch adenoma formation was 8.32 (1.42-48.80; P=0.019) for the indel/deletion group versus nonsense/missense, but no significant independent association was noted with mutation location. The mean number of pouch and cuff adenoma formation (per endoscopy) was higher among carriers of exon 15 mutations, but no significant independent association was noted the with mutation type. Conclusions: Type and location of APC mutation are associated with colonic polyp burden, surgical outcome and likelihood of developing pouch adenomas. These findings may contribute to surgical and endoscopic surveillance decisions for FAP patients.

[1]  M. Hegde,et al.  Detecting APC Gene Mutations in Familial Adenomatous Polyposis (FAP) , 2017, Current protocols in human genetics.

[2]  C. Dodaro,et al.  The role of mutation analysis of the APC gene in the management of FAP patients. A controversial issue. , 2016, Annali italiani di chirurgia.

[3]  H. Tulchinsky,et al.  Patterns of Adenoma Recurrence in Familial Adenomatous Polyposis Patients after Ileal Pouch-Anal Anastomosis , 2015, Digestive Surgery.

[4]  Peter Nürnberg,et al.  Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas , 2015, International journal of cancer.

[5]  L. Moreira,et al.  The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management , 2015, The application of clinical genetics.

[6]  Mads Thomassen,et al.  Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. , 2015, JAMA.

[7]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[8]  S. Gruber,et al.  Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  S. Kumar,et al.  Pouch adenomas in Familial Adenomatous Polyposis after restorative proctocolectomy. , 2015, International journal of surgery.

[10]  H. Järvinen,et al.  Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis , 2015, Familial Cancer.

[11]  F. Campos.  Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. , 2014, World journal of gastroenterology.

[12]  C. Béroud,et al.  The UMD–APC Database, a Model of Nation‐Wide Knowledge Base: Update with Data from 3,581 Variations , 2014, Human mutation.

[13]  Arupa Ganguly,et al.  ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis) , 2013, Genetics in Medicine.

[14]  H. Järvinen,et al.  Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis , 2014, International Journal of Colorectal Disease.

[15]  Y. Niwa,et al.  Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis. , 2013, World journal of gastroenterology.

[16]  D. Carraro,et al.  Mutational spectrum of the APC and MUTYH genes and genotype–phenotype correlations in Brazilian FAP, AFAP, and MAP patients , 2013, Orphanet Journal of Rare Diseases.

[17]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[18]  A. Herline,et al.  Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis. , 2013, World journal of colorectal surgery.

[19]  F. Lalloo,et al.  Genotype–phenotype correlation in colorectal polyposis , 2012, Clinical genetics.

[20]  Z. Halpern,et al.  A protocol for genetic evaluation of patients with multiple colorectal adenomas and without evidence of APC gene mutation. , 2010, The Israel Medical Association journal : IMAJ.

[21]  D. Evans,et al.  The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis , 2010, Gut.

[22]  E. Bakker,et al.  Genotype–phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review , 2007, European Journal of Human Genetics.

[23]  J. Kleibeuker,et al.  Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  M. Nieuwenhuis,et al.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. , 2007, Critical reviews in oncology/hematology.

[25]  M. Leppert,et al.  Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. , 2004, Gastroenterology.

[26]  I. Tomlinson,et al.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases , 2004, Gut.

[27]  J. Church,et al.  Anal Transitional Zone Cancer After Restorative Proctocolectomy and Ileoanal Anastomosis in Familial Adenomatous Polyposis , 2003, Diseases of the colon and rectum.

[28]  S. Bülow,et al.  Results of national registration of familial adenomatous polyposis , 2003, Gut.

[29]  J. Gebert,et al.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families , 2001, Gut.

[30]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[31]  C. Tops,et al.  Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis , 1996, The Lancet.

[32]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[33]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[34]  V. Fazio,et al.  Mortality in patients with familial adenomatous polyposis , 1990, Diseases of the colon and rectum.